Biotech Hedge Funds: A Match Made in Heaven
Mergers and Inquisitions
MARCH 5, 2025
their Enterprise Values are not worth much for a long time): Hedge funds focusing on public biotech companies step into this process after the IPO part, which means they can bet on extreme value inflections based on binary outcomes. Other large funds include Perceptive Advisors, RA Capital, and RTW.
Let's personalize your content